Showing results (421-430 of 484) with videos related to
Sort By:
Pageof 49
Pathology|September 24, 2020
Prognostic features of Annexin A2 expression in prostate cancerShyh-Han Tan, Denise Young, Yongmei Chen, et al.International Journal of Oncology|November 18, 2004
Preclinical testing of a peptide-based, HER2/neu vaccine for prostate cancerMichael M Woll, Matthew T Hueman, Gayle B Ryan, et al.The Journal of Urology|April 11, 2003
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomyJason C Massengill, Leon Sun, Judd W Moul, et al.Surgery|September 10, 2002
Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national databaseJudd W Moul, Hongyu Wu, Leon Sun, et al.Pathology International|September 18, 2010
Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumorsAmina Ali, Bungo Furusato, Paul O P Ts'o, et al.Nature Genetics|March 1, 1994
A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsiesG A Nicholson, L J Valentijn, A K Cherryson, et al.Frontiers in Oncology|February 12, 2021
Age and Tumor Differentiation-Associated Gene Expression Based Analysis of Non-Familial Prostate CancersShashwat Sharad, Travis C Allemang, Hua Li, et al.Oncogene|December 17, 2002
Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cellsTakehiko Segawa, Martin E Nau, Linda L Xu, et al.Cancer Biology & Therapy|December 24, 2010
ERG oncogene modulates prostaglandin signaling in prostate cancer cellsAhmed A Mohamed, Shyh-Han Tan, Chen Sun, et al.Epigenetics|April 4, 2014
Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancerShashwat Sharad, Lakshmi Ravindranath, Michael C Haffner, et al.Pageof 49